Walgreen Boots Alliance (WBA) Tops Q2 EPS by 23c

Rite Aid (RAD) Bounces Off Lows

Rite Aid (NYSE: RAD) shares bounced off lows near $8.10 late on Friday morning. The stock was pressured the last two sessions following its Q4 results and due to M&A-related comments made during Walgreen Boots Alliance's (NASDAQ:... More

Deutsche Bank Comments Following Walgreens Boosts (WBA) Q2 Results (ESRX)

Deutsche Bank maintained a Buy rating on Walgreens Boosts Alliance (NASDAQ: WBA) with a price target of $89. Comments follow Q2 results. Analyst George Hill pointed out guidance was in line with the Street. He also touched on rumors it could acquire Express Scripts (NASDAQ: ESRX).

"Walgreens reported F2Q15 results that exceeded expected EPS expectations... More

Evercore ISI Discusses Walgreens Boosts Alliance (WBA) M&A and JVs

Speculation has been hot in the PBM/Pharmacy space today following Walgreens Boosts Alliance (NASDAQ: WBA) earnings conference call. Evercore ISI analyst Ross Muken offer his thoughts on the situation in a note to clients this afternoon.

Read-through to ESRX (Nasdaq: ESRX): The market clearly interpreted today's commentary on the CC as an open invitation for talks with key peer ESRX. While we believe some sort of relationship has a ton of merit... More

Walgreens (WBA) Likely to Pursue Acquisition or JV Near-Term, Leerink Says (RAD) (ABC) (ESRX)

Leerink Partners analyst David Larsen weighed in on Walgreens Boosts Alliance (NASDAQ: WBA) after today's earnings. The analyst notes management is aggressively pursuing new U.S. retail synergies and M&A is on the horizon. The firm maintained an Outperform rating and price target of $85.00

Larsen commented, "During the call management indicated that... More